British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024
Esther L. Moss, Alexandra Taylor, Adrian Andreou, Christine Ang, Rupali Arora, Ayoma D. Attygalle, Susana Banerjee, Rebecca Bowen, Lynn Buckley, Nikos Burbos, Sarah Coleridge, Richard J. Edmondson, Mona El‐Bahrawy, Christina Fotopoulou, Jonathan Frost, Raji Ganesan, Angela George, Louise Hanna, Baljeet Kaur, Ranjit Manchanda, Hillary Maxwell, Agnieszka Michael, Tracey Miles, Claire Newton, Shibani Nicum, Nithya Ratnavelu, Neil Ryan, Sudha Sundar, Katherine Vroobel, Axel Walther, Jason T. Wong, Jo Morrison
Abstract
<p dir="ltr">Recommendations are graded as per the Royal College of Obstetricians and Gynaecologists document, Clinical Governance Advice No. 1: Guidance for the Development of RCOG Green-top Guidelines, available on the RCOG website at (see Supplementary Tables 1 and 2 below and at www.rcog.org.uk/rcog). Definitions for certainty of evidence based on formal GRADE assessment within systematic reviews are given in Supplementary Table 3 [677].</p><p dir="ltr">This guideline is for healthcare professionals who care for women, non-binary and trans people with different types of tubo-ovarian cancer. Within this document we use the terms woman and women’s health. However, it is important to acknowledge that it is not only women for whom it is necessary to access women’s health and reproductive services in order to maintain their gynaecological health and reproductive wellbeing. Gynaecological services and delivery of care must therefore be appropriate, inclusive and sensitive to the needs of those individuals whose gender identity does not align with the sex they were assigned at birth [1].</p><p dir="ltr"><br></p>